319 related articles for article (PubMed ID: 36165137)
1. Clinical significance of UbA52 level in the urine of patients with type 2 diabetes mellitus and diabetic kidney disease.
Xu X; Dong Y; Liu M; Li Y; Zhang Y
Nefrologia (Engl Ed); 2021; 41(5):548-555. PubMed ID: 36165137
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic value of serum cathepsin S in type 2 diabetic kidney disease.
Ren X; Wang W; Cao H; Shao F
Front Endocrinol (Lausanne); 2023; 14():1180338. PubMed ID: 37305031
[TBL] [Abstract][Full Text] [Related]
3. Assessment of urinary NGAL for differential diagnosis and progression of diabetic kidney disease.
Duan S; Chen J; Wu L; Nie G; Sun L; Zhang C; Huang Z; Xing C; Zhang B; Yuan Y
J Diabetes Complications; 2020 Oct; 34(10):107665. PubMed ID: 32653382
[TBL] [Abstract][Full Text] [Related]
4. Characterization of diabetic nephropathy by urinary proteomic analysis: identification of a processed ubiquitin form as a differentially excreted protein in diabetic nephropathy patients.
Dihazi H; Müller GA; Lindner S; Meyer M; Asif AR; Oellerich M; Strutz F
Clin Chem; 2007 Sep; 53(9):1636-45. PubMed ID: 17634209
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic value of triglyceride and cystatin C ratio in diabetic kidney disease: a retrospective and prospective cohort study based on renal biopsy.
Wei J; Wang B; Shen FJ; Zhang TT; Duan Z; Zhou DM
BMC Nephrol; 2022 Jul; 23(1):270. PubMed ID: 35896961
[TBL] [Abstract][Full Text] [Related]
6. Serum high mobility group box 1 as a potential biomarker for the progression of kidney disease in patients with type 2 diabetes.
Liu T; Zhao H; Wang Y; Qu P; Wang Y; Wu X; Zhao T; Yang L; Mao H; Peng L; Zhan Y; Li P
Front Immunol; 2024; 15():1334109. PubMed ID: 38481996
[TBL] [Abstract][Full Text] [Related]
7. Serum Human Epididymis Protein 4 is Associated with Renal Function and Diabetic Kidney Disease in Patients with Type 2 Diabetes Mellitus.
Zhang M; Zhao B; Xie J; Liang Y; Yang Z
Biomed Res Int; 2019; 2019():4831459. PubMed ID: 31815140
[TBL] [Abstract][Full Text] [Related]
8. Serum lutein is a promising biomarker for type 2 diabetes mellitus and diabetic kidney disease in the elderly.
Pan F; Cui W; Gao L; Shi X; Yang H; Hu Y; Li M
J Clin Lab Anal; 2022 Apr; 36(4):e24350. PubMed ID: 35293029
[TBL] [Abstract][Full Text] [Related]
9. Predictive value of ferroptosis-related biomarkers for diabetic kidney disease: a prospective observational study.
Wu Y; Sun Y; Wu Y; Zhang K; Chen Y
Acta Diabetol; 2023 Apr; 60(4):507-516. PubMed ID: 36633709
[TBL] [Abstract][Full Text] [Related]
10. Uromodulin mRNA from Urinary Extracellular Vesicles Correlate to Kidney Function Decline in Type 2 Diabetes Mellitus.
Yamamoto CM; Murakami T; Oakes ML; Mitsuhashi M; Kelly C; Henry RR; Sharma K
Am J Nephrol; 2018; 47(5):283-291. PubMed ID: 29779026
[TBL] [Abstract][Full Text] [Related]
11. Association between neutrophil-to-lymphocyte ratio and diabetic kidney disease in type 2 diabetes mellitus patients: a cross-sectional study.
Li X; Wang L; Liu M; Zhou H; Xu H
Front Endocrinol (Lausanne); 2023; 14():1285509. PubMed ID: 38239986
[TBL] [Abstract][Full Text] [Related]
12. Pentraxin-3 and adropin as inflammatory markers of early renal damage in type 2 diabetes patients.
Li B; Tian X; Guo S; Zhang M; Li J; Zhai N; Wang H; Zhang Y
Int Urol Nephrol; 2020 Nov; 52(11):2145-2152. PubMed ID: 32661627
[TBL] [Abstract][Full Text] [Related]
13. Implications of increased circulating macrophage inhibitory protein-5 in patients with type 2 diabetes mellitus.
Zhao B; Zhang M; Xie J; Jiang T; Li J; Yang Z
Int Immunopharmacol; 2022 Aug; 109():108916. PubMed ID: 35679662
[TBL] [Abstract][Full Text] [Related]
14. Serum and Urinary Progranulin in Diabetic Kidney Disease.
Nicoletto BB; Krolikowski TC; Crispim D; Canani LH
PLoS One; 2016; 11(10):e0165177. PubMed ID: 27776152
[TBL] [Abstract][Full Text] [Related]
15. Urinary exosomal microRNA-145-5p and microRNA-27a-3p act as noninvasive diagnostic biomarkers for diabetic kidney disease.
Han LL; Wang SH; Yao MY; Zhou H
World J Diabetes; 2024 Jan; 15(1):92-104. PubMed ID: 38313849
[TBL] [Abstract][Full Text] [Related]
16. The link between diabetic retinal and renal microvasculopathy is associated with dyslipidemia and upregulated circulating level of cytokines.
Chen X; Zhang X; Gong Z; Yang Y; Zhang X; Wang Q; Wang Y; Xie R
Front Public Health; 2022; 10():1040319. PubMed ID: 36733289
[TBL] [Abstract][Full Text] [Related]
17. Assessment of two novel renal tubular proteins in type 2 diabetic patients with nephropathy.
Abdel Ghafar MT; Shalaby KH; Okda HI; Abo El Gheit RE; Soliman NA; Keshk WA
J Investig Med; 2020 Mar; 68(3):748-755. PubMed ID: 31722957
[TBL] [Abstract][Full Text] [Related]
18. Diabetic Nephropathy Can Be Treated with Calcium Dobesilate by Alleviating the Chronic Inflammatory State and Improving Endothelial Cell Function.
Zhou Y; Qi C; Li S; Shao X; Mou S; Ni Z
Cell Physiol Biochem; 2018; 51(3):1119-1133. PubMed ID: 30476916
[TBL] [Abstract][Full Text] [Related]
19. Assessment of urinary podocalyxin as an alternative marker for urinary albumin creatinine ratio in early stage of diabetic kidney disease in older patients.
Xie Y; Jin D; Qiu H; Lin L; Sun S; Li D; Sha F; Zhou W; Jia M
Nefrologia (Engl Ed); 2022; 42(6):664-670. PubMed ID: 36402681
[TBL] [Abstract][Full Text] [Related]
20. 12(S)-hydroxyeicosatetraenoic acid is significantly increased in diabetic kidney disease and associated with renal function decline.
Xu J; Jin L; Sun Y; Zhang R; Chen X; Zhou R; Gu Y; Hu C
Diabetes Metab Res Rev; 2022 Sep; 38(6):e3554. PubMed ID: 35667014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
